Skip to main content
logo
Argenica Therapeutics Limited (ASX:AGN)
Australia flag Australia · Delayed Price · Currency is AUD
0.1500
-0.0050 (-3.23%)
Aug 5, 2026, 1:04 PM AEST

Argenica Therapeutics Financials Overview

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Revenue
1.013.212.61.750.260.3
Revenue Growth
-68.68%23.70%48.46%575.38%-12.49%-
Gross Profit
1.013.212.61.750.260.3
Operating Income
-10.13-7.68-5.67-4.87-4.09-1.03
Net Income
-9.8-7.17-5.48-4.82-4.09-1.03
Earnings Per Share
-0.08-0.06-0.05-0.07-0.06-0.03
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Net Cash (Debt)
5.0410.5615.919.348.917.14
Net Cash Growth
-52.28%-33.67%70.39%4.76%24.78%1989.04%
Net Cash Per Share
0.040.080.150.130.120.20
Cash & Investments
5.0410.5615.919.348.917.14

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Operating Cash Flow
-10.04-5.7-5.06-3.3-3.36-1.05
Free Cash Flow
-10.04-5.7-5.06-3.3-3.36-1.05
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-1006.58%-239.05%-218.30%-278.59%-1579.49%-347.76%
Pretax Margin
-973.56%-223.11%-210.92%-275.16%-1578.84%-347.70%
Profit Margin
-973.56%-223.12%-210.92%-275.16%-1578.84%-347.72%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
PS Ratio
19.1430.3837.2621.08144.2649.43